CRON Cronos Group Inc. Common Share Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:54
Aug 25
Aug 25
Cronos balance sheet favored over US cannabis.
Cronos is cited as having a stronger balance sheet than U.S. cannabis companies; no explicit directional trade call is made.
MED
13:19
Aug 25
Aug 25
CRON long on cash, buybacks, FDA catalyst
Author took a position in CRON via spot and calls, citing a pristine balance sheet, $825M net cash, EBITDA positivity, near-book valuation, and buybacks, with potential FDA deregulation catalyst as an upside driver.
MED
19:46
Aug 24
Aug 24
Author explicitly states CRON is the best play and took a position today at 3.37.
Author explicitly states CRON is the best play and took a position today at 3.37, a clear long entry.
11:27
Aug 15
Aug 15
The author is compiling a research thread of user-recommended non-AI tickers.
The author is compiling a research thread of user-recommended non-AI tickers, listing them as a factual watchlist
LOW
19:51
Aug 10
Aug 10
CRON posted strong quarterly results
CRON reported a strong quarter last week, a fundamental earnings event cited as part of a broader positive trend in Canadian cannabis LPs.
LOW
About CRON Analyst Coverage
Buzzberg tracks CRON (Cronos Group Inc. Common Share) across 3 sources. 1 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (20%). 5 total trade ideas tracked. Latest voices: CryptoCondom, thebigberbowski, stocks_stones.